WO2012000356A1 - Quinazoline compounds - Google Patents

Quinazoline compounds Download PDF

Info

Publication number
WO2012000356A1
WO2012000356A1 PCT/CN2011/074637 CN2011074637W WO2012000356A1 WO 2012000356 A1 WO2012000356 A1 WO 2012000356A1 CN 2011074637 W CN2011074637 W CN 2011074637W WO 2012000356 A1 WO2012000356 A1 WO 2012000356A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
cancer
pyrrole
yl
carboxamide
methylhexahydropyrrolo
Prior art date
Application number
PCT/CN2011/074637
Other languages
English (en)
French (fr)
Inventor
Weihan Zhang
Wei-Guo Su
Haibin Yang
Yumin Cui
Yongxin Ren
Xiaoqiang Yan
Original Assignee
Hutchison Medipharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
PCT/CN2011/074637 2010-06-30 2011-05-25 Quinazoline compounds WO2012000356A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2010/074792 2010-06-30
PCT/CN2010/074792 WO2012000182A1 (en) 2010-06-30 2010-06-30 Quinazoline compounds

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US13807460 US9168253B2 (en) 2010-06-30 2011-05-25 Quinazoline compounds
DK11800101T DK2590966T3 (en) 2010-06-30 2011-05-25 quinazoline
CN 201180024971 CN102906086B (zh) 2010-06-30 2011-05-25 喹唑啉化合物
ES11800101T ES2604929T3 (es) 2010-06-30 2011-05-25 Compuestos de quinazolina
CA 2801814 CA2801814C (en) 2010-06-30 2011-05-25 Quinazoline compounds
RU2012153174A RU2530887C2 (ru) 2010-06-30 2011-05-25 Соединения хиназолина
EP20110800101 EP2590966B1 (en) 2010-06-30 2011-05-25 Quinazoline compounds
JP2013516973A JP5736452B2 (ja) 2010-06-30 2011-05-25 キナゾリン化合物
KR20137001865A KR101480481B1 (ko) 2010-06-30 2011-05-25 퀴나졸린 화합물

Publications (1)

Publication Number Publication Date
WO2012000356A1 true true WO2012000356A1 (en) 2012-01-05

Family

ID=45401313

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/CN2010/074792 WO2012000182A1 (en) 2010-06-30 2010-06-30 Quinazoline compounds
PCT/CN2011/074637 WO2012000356A1 (en) 2010-06-30 2011-05-25 Quinazoline compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/074792 WO2012000182A1 (en) 2010-06-30 2010-06-30 Quinazoline compounds

Country Status (9)

Country Link
US (1) US9168253B2 (pt-PT)
EP (1) EP2590966B1 (pt-PT)
JP (1) JP5736452B2 (pt-PT)
KR (1) KR101480481B1 (pt-PT)
CA (1) CA2801814C (pt-PT)
DK (1) DK2590966T3 (pt-PT)
ES (1) ES2604929T3 (pt-PT)
RU (1) RU2530887C2 (pt-PT)
WO (2) WO2012000182A1 (pt-PT)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140093271A (ko) 2011-11-14 2014-07-25 선샤인 레이크 파르마 컴퍼니 리미티드 아미노퀴나졸린 유도체, 그의 염 및 이용 방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
CN101619043A (zh) * 2008-06-30 2010-01-06 和记黄埔医药(上海)有限公司 喹唑啉衍生物及其医药用途
WO2010002845A2 (en) 2008-06-30 2010-01-07 Hutchison Medipharma Enterprises Limited Quinazoline derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
CN101619043A (zh) * 2008-06-30 2010-01-06 和记黄埔医药(上海)有限公司 喹唑啉衍生物及其医药用途
WO2010002845A2 (en) 2008-06-30 2010-01-07 Hutchison Medipharma Enterprises Limited Quinazoline derivatives

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"Encyclopedia of Reagents for Organic Synthesis", 1995, JOHN WILEY AND SONS
L. FIESER; M. FIESER: "Fieser and Fieser 's Reagents for Organic Synthesis", 1994, JOHN WILEY AND SONS
R. LAROCK: "Comprehensive Organic Transformations", 1989, VCH PUBLISHERS
See also references of EP2590966A4 *
T.W. GREENE; P.G.M. WUTS: "Protective Groups in Organic Synthesis", 1999, JOHN WILEY AND SONS

Also Published As

Publication number Publication date Type
US20130172373A1 (en) 2013-07-04 application
KR20130031358A (ko) 2013-03-28 application
RU2012153174A (ru) 2014-08-10 application
EP2590966B1 (en) 2016-08-31 grant
EP2590966A4 (en) 2014-01-15 application
KR101480481B1 (ko) 2015-01-09 grant
WO2012000182A1 (en) 2012-01-05 application
RU2530887C2 (ru) 2014-10-20 grant
EP2590966A1 (en) 2013-05-15 application
ES2604929T3 (es) 2017-03-10 grant
JP2013529653A (ja) 2013-07-22 application
CA2801814C (en) 2015-04-07 grant
CA2801814A1 (en) 2012-01-05 application
JP5736452B2 (ja) 2015-06-17 grant
US9168253B2 (en) 2015-10-27 grant
DK2590966T3 (en) 2016-12-19 grant

Similar Documents

Publication Publication Date Title
US7166293B2 (en) Angiogenesis inhibitors
US20040152759A1 (en) Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
WO2004080462A1 (ja) c-Kitキナーゼ阻害剤
US20080167292A1 (en) Compounds for inhibiting mitotic progression
CN103159742A (zh) 5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
Carmi et al. Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer
WO2015144804A1 (en) Combinations
WO2015144803A1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
Marzaro et al. Quinazoline derivatives as potential anticancer agents: a patent review (2007–2010)
WO2013020062A1 (en) Quinazoline compounds as serine/threonine kinase inhibitors
WO2009109605A1 (en) Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
WO2010104406A1 (en) Prodrug forms of kinase inhibitors and their use in therapy
WO2015006754A2 (en) Heterocyclic compounds and uses thereof
WO2014143601A1 (en) CDC7 Inhibitors
JP2007505161A (ja) Parpを阻害するための化合物、方法、および医薬組成物
WO2011050016A1 (en) Akt inhibitors
WO2015158310A1 (zh) 一种酪氨酸激酶抑制剂及其用途
WO2012125904A1 (en) Mutation mimicking compounds that bind to the kinase domain of egfr
JP5475888B2 (ja) タンパク質キナーゼ阻害剤としての化合物および組成物
US9359368B2 (en) Crystals of dispiropyrrolidine derivatives
US20070135473A1 (en) Method of treating tumors with azaxanthones
JP2012508223A (ja) トリアジン、ピリミジン、及びピリジン類似体、並びに、治療薬及び診断プローブとしてのそれらの使用
WO2009137797A2 (en) Quinazoline derivatives
CN102675287A (zh) (e)-n-[4-[[3-氯-4-(2-吡啶基甲氧基)苯基]氨基]-3-氰基-7-乙氧基-6-喹啉基]-3-[(2r)-1-甲基吡咯烷-2-基]丙-2-烯酰胺的可药用的盐、其制备方法及其在医药上的应用
US20130165458A1 (en) Quinazoline compounds as kinase inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11800101

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase in:

Ref document number: 2801814

Country of ref document: CA

ENP Entry into the national phase in:

Ref document number: 2013516973

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase in:

Ref country code: DE

ENP Entry into the national phase in:

Ref document number: 2011274183

Country of ref document: AU

Date of ref document: 20110525

Kind code of ref document: A

ENP Entry into the national phase in:

Ref document number: 20137001865

Country of ref document: KR

Kind code of ref document: A

REEP

Ref document number: 2011800101

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: 2012153174

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13807460

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012033344

Country of ref document: BR

ENP Entry into the national phase in:

Ref document number: 112012033344

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20121227